Rick Kanner, EMBA '19, is Senior Director of Oncology Market Access at Eli Lilly in Indianapolis, IN.
Takeda is a global biopharmaceutical corporation with an ambitious zero-waste-to-landfill goal. BioLife, a subsidiary of Takeda, sought to develop prioritized recycling strategies in support of Takeda’s sustainability pledge and goals. A team of three Sustainable Business Lab (S-Lab) students tackle...
Bloomer Tech designed a washable bra that uses flexible and washable circuits to continuously read metrics like their ECG, respiration, heart rate, and more.
Sergio Medina, EMBA ’20, is the founder and CEO of the social enterprise RISE in San Francisco, CA.
Dr. Robert Faiella, EMBA '17, is Chief Dental Officer of Overjet and Past President of the American Dental Association.
Kathleen Stetson, MBA ’14, joins Christopher Reichert, MOT ’04, on this episode of Sloanies Talking with Sloanies.
Pandemic defense requires a massive government program that engages the private sector; the public sector cannot and has not been able to handle health security problems of scale. However, relevant capabilities for invention, production, and distribution exist both in commerce and higher education. ...
Candice Creecy, SFMBA ’22, is a consultant at McKinsey & Company focusing on life sciences and healthcare. She's also an emergency medicine physician assistant at Brigham and Women’s Hospital.
The MIT Sloan MBA Class of 2020 persevered despite a global pandemic, an increasingly difficult job market, and many other ongoing challenges. New graduates like Carolina Goncebat, MBA ’20, have since succeeded in making their mark in numerous industries across the globe.
From designing and creating environmentally sound materials to fostering connections between organizations and inclusivity experts, ventures founded and managed by MIT and MIT Sloan alumnae are making positive impacts on the world.
